Skip to main content
SpringerPlus

Table 3 Vertigo frequency before and after treatment with cinnarizine

From: Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study

Variable, mean ± SD

Total vertigo population (n = 40)

Subgroups

 

Vestibular migraine (n = 24)

Migraine with brainstem aura (n = 16)

p-value1

Monthly frequency of vertigo attacks

    

At baseline

3.68 ± 1.05

3.79 ± 1.14

3.50 ± 0.89

0.372

12-week treatment period

    

 1st 4-week

1.30 ± 1.07*

1.54 ± 1.10*

0.94 ± 0.93*

0.079

 2nd 4-week

0.60 ± 0.67*

0.79 ± 0.72*

0.31 ± 0.48*

0.016

 3rd 4-week

0.35 ± 0.65*

0.42 ± 0.65*

0.25 ± 0.58*

0.402

  1. *p < 0.05 compared with baseline.
  2. 1p-value for comparison between vestibular migraine and migraine with brainstem aura.
Back to article page